ChemAxon is a leader in cheminformatics for the chemistry, pharmaceutical, and agrochemical industries. Innoplexus is a leader in artificial intelligence and blockchain for the life sciences industry. This partnership will leverage a ChemAxon product, ChemLocator, that allows researchers to search all potential, pre-clinical, clinical or marketed drugs in documents across data assets in Innoplexus' product, Ontosight®. This symbiotic combination will provide the industry with relevant signals much earlier than by traditional methods.

ChemLocator is a web-based search tool with chemical recognition capabilities that allows users to find hidden chemical knowledge and extract structures from documents. By combining ChemLocator with Ontosight®, users will be able to discover otherwise unavailable information in public domains or "forgotten" information in enterprise archives. Times to find chemicals and compounds using name or chemical properties will be significantly reduced, overall accelerating research that utilized non-obvious findings and unexplored whitespaces.

"The 4th Industrial Revolution is changing the world, and we are glad to be partnering with a leading AI company to tackle one of the most exciting challenges in the automated data process." says David Jozsef, Product Owner of ChemLocator at ChemAxon. "We believe extracting chemical structures from scientific literature and facilitating meaningful questions related to those will leverage the transformation of existing information into novel ideas. We truly believe that our integration with Ontosight® will open up new perspectives for life sciences R&D."

"We look forward to integrating ChemLocator into Ontosight® to be able to deliver new possibilities to our clients together" expressed Vatsal Agarwal, Vice President - Artificial Intelligence & Computational Linguistics at Innoplexus.

ChemAxon is a chemical and biological software development company that provides solutions for the biotechnology and pharmaceutical industries. Innoplexus is an Industry validated, AI-powered, Drug Discovery and Development platform creating value for diverse stakeholders by driving Innovation in science, clinical development and commercialization.